Sign in
CompletedNo phase

Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy

Key facts

Who runs it
Horus University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
30 people enrolled
Started
1 Aug 2025
Ended
1 Mar 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Low level laser
  • Transcutaneous auricular Vagus nerve stimulation
Record updated
20 May 2026

Who can take part

Age
45 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • The patient selection will be according to the following criteria:
  • 30 patients diagnosed with diabetic neuropathy from both genders their ages will be ranged from 45-60 years old
  • All patients are ambulant independently
  • All patients are under full medical control
  • Glycated hemoglobin is ranged from 6.5: 7 %
  • Patients have had diabetes for more than 5 or 10 years
  • patients experiencing painful peripheral neuropathic symptoms for more than 6 months involving both lower extremities and complained of burning pain with paresthesia in both legs; 7 Neurological examination revealed abnormal sensation appeared at the ends of the extremities

Who cannot take part

  • Nerve damage as a result of prior reconstructive or replacement knee surgery, back surgery, spinal stenosis, spinal compression or radiculopathy
  • Patients had unstable glycemic control and/or medical conditions that would confound assessment of neuropathy such as malignancy, active/untreated thyroid disease, peripheral vascular diseases, vascular insufficiency (claudication, skin discoloration, ulceration)
  • Following the implantation of cardiac pacemakers or other electrical stimulation devices
  • Patients whose heart rate dropped below 50 beats/min after vagus nerve stimulation
  • Patient had sinus bradycardia, long QT syndrome, or other arrhythmias or mental disorders

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To compare the effect of both low-level laser versus transcutaneous vagus nerve stimulation on vascular changes in patients with diabetic polyneuropathy

The 2 groups in the trial

  • Low Level LaserTreatment being tested

    Patients will receive Low Level Laser irradiated with two wavelengths of visible 630 nm and near infra-red 810 nm for 15 min on entire surface of each foot three times a week for 2 months

  • Transcutaneous auricular Vagus nerve stimulationExisting treatment, for comparison

    Patients will receive 30 minutes Transcutaneous auricular Vagus nerve stimulation 3 sessions per week for 2 months.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Low Level Laser Versus Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy
Record updated
20 May 2026